INTERNATIONAL PATENT: ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) FILES APPLICATION FOR "ENHANCEMENT OF T CELL MEDIATED THERAPIES WITH A DNA HYPOMETHYLATING AGENT AND A SUMOYLATION INHIBITOR"

GENEVA, April 1 -- ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) (Albinusdreef 22333 ZA Leiden) filed a patent application (PCT/NL2024/050510) for "ENHANCEMENT OF T CELL MEDIATED THERAPIES WITH A DNA HYPOMETHYLATING AGENT AND A SUMOYLATION INHIBITOR" on Sep 19, 2024. With publication no. WO/2025/063844, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VERTEGAAL, Alfredus Cornelis Otto (c/o Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)Albinusdreef 22333 ZA Leiden), HEEMSKERK, Mirjam H.M. (c/o Academisch Ziekenhuis Leiden (h.o...